- Home
- ELDN vs SILC Comparison
ELDN vs SILC Comparison
Compare ELDN & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELDN | SILC |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.8M | 263.8M |
| IPO Year | 2014 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ELDN | SILC |
|---|---|---|
| Price | $2.13 | $40.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 758.2K | 147.7K |
| Earning Date | 11-13-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $52.16 |
| Revenue Next Year | N/A | $19.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $13.34 |
| 52 Week High | $4.60 | $63.00 |
Technical Indicators
Market Signals| Indicator | ELDN | SILC |
|---|---|---|
| Relative Strength Index (RSI) | 25.06 | 34.92 |
| Support Level | $1.96 | $38.00 |
| Resistance Level | $2.30 | $49.51 |
| Average True Range (ATR) | 0.13 | 3.84 |
| MACD | -0.00 | -2.06 |
| Stochastic Oscillator | 6.00 | 3.48 |
Price Performance
Historical ComparisonAbout ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
About SILC Silicom Ltd
Silicom Ltd is engaged in designing, manufacturing, marketing, and supporting high-performance networking and data infrastructure solutions for a broad range of servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, Switches, Edge AI Solutions, Edge Networking Accessories, 4G 5G Products, FPGA-Based Cards, and Others. Its geographic areas are the USA, North America - other, Israel, Europe, and Asia-Pacific. It derives a majority of its revenue from the USA.